Clinical trial
TAXUS II: A Randomized, Double-Blind, Controlled Study of the Safety and Performance of the NIRx™ Paclitaxel-Coated Conformer Coronary Stent
NCT00299026 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- TAXUS II: A Randomized, Double-Blind, Controlled Study of the Safety and Performance of the NIRx™ Paclitaxel-Coated Conformer Coronary Stent
- Lead sponsor
- Boston Scientific Corporation
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- June 30, 2001
- Completion date
- February 28, 2007
- Enrollment
- 532
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.